Treatment of skin and soft tissue infections in the Elderly: A review

American Journal Geriatric Pharmacotherapy

Volumn 8, Issue 6, 2010, Pages 485-513

  Kish, Troy D ^a   Chang, Mei H ^a   Fung, Horatio B ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

community acquired methicillin resistant Staphylococcus aureus; diabetic foot infections; elderly; infected pressure ulcers; shingles; skin and soft tissue infection

Indexed keywords

AZITHROMYCIN; AZTREONAM; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CEFALEXIN; CEFAZOLIN; CEFPODOXIME; CEPHALOSPORIN; CIPROFLOXACIN; CLINDAMYCIN; CLOXACILLIN; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; DICLOXACILLIN; ERYTHROMYCIN; FLUCLOXACILLIN; LEVOFLOXACIN; LINEZOLID; MACROLIDE; METRONIDAZOLE; MOXIFLOXACIN; NAFCILLIN; OFLOXACIN; OXACILLIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TELAVANCIN; TIGECYCLINE; UNINDEXED DRUG; VANCOMYCIN;

ABSCESS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL LOAD; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CELLULITIS; DECUBITUS; DIABETIC FOOT; DIARRHEA; DRUG EFFICACY; DRUG ERUPTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; ERYSIPELAS; HERPES ZOSTER; HOSPITAL INFECTION; HUMAN; INFECTION RISK; INJECTION SITE INFLAMMATION; INJECTION SITE PAIN; KIDNEY DISEASE; LOADING DRUG DOSE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NAUSEA; PATHOGENESIS; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SCABIES; SIDE EFFECT; SKIN AND SOFT TISSUE INFECTION; SKIN DISEASE; SKIN INFECTION; SOFT TISSUE INFECTION; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; STREPTOCOCCUS INFECTION; SURGICAL INFECTION; TASTE DISORDER; THROMBOCYTOPENIA; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; VOMITING; WOUND INFECTION;

EID: 79952161038     PISSN: 15435946     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1543-5946(10)80002-9     Document Type: Article

References (151)

1. V Ki, and C Rotstein Bacterial skin and soft tissue infections in adults: A review of their epi (Pubitemid 351754184)
2. LJ Eron, BA Lipsky, DE Low Expert Panel on Managing Skin and Soft Tissue Infections Managing skin and soft tissue infections: Expert panel recommendations on key decision points J Antimicrob Chemother 52 Suppl 1 2003 i3 i17
3. FM Abrahamian, DA Talan, and GJ Moran Management of skin and soft-tissue infections in the emergency department Infect Dis Clin North Am 22 2008 89 116 vi (Pubitemid 351273541)
4. BA Lipsky, JA Weigelt, and V Gupta Skin, soft tissue, bone, and joint infections in hospitalized patients: Epidemiology and microbiological, clinical, and economic outcomes Infect Control Hosp Epidemiol 28 2007 1290 1298 (Pubitemid 47596568)
5. DJ Pallin, JA Espinola, and DY Leung Epidemiology of dermatitis and skin infections in United States physicians' offices, 1993-2005 Clin Infect Dis 49 2009 901 907
6. SM Ellis Simonsen, ER van Orman, and BE Hatch Cellulitis incidence in a defined population Epidemiol Infect 134 2006 293 299 (Pubitemid 43280237)
7. DJ Anderson, and KS Kaye Skin and soft tissue infections in older adults Clin Geriatr Med 23 2007 595 613 vii (Pubitemid 47042343)
8. H Chen, AP Chiu, and PS Lam Prevalence of infections in residential care homes for the elderly in Hong Kong Hong Kong Med J 14 2008 444 450
9. L Tsan, C Davis, and R Langberg Prevalence of nursing home-associated infections in the Department of Veterans Affairs nursing home care units Am J Infect Control 36 2008 173 179 (Pubitemid 351417672)
10. Standards, Practice Guidelines, and Statements Developed and/or Endorsed by IDSA https://www.idsociety.org/Content.aspx?id=9088 March 30, 2010 Accessed
11. FH Martini, MJ Timmons, and RB Tallitsch Human Anatomy 4th ed 2003 Prentice Hall Upper Saddle River, NJ 86 106
12. P Diggory, A Homer, and J Liddle Medicine in the elderly Postgrad Med J 67 1991 423 445
13. TH Htwe, A Mushtaq, and SB Robinson Infection in the elderly Infect Dis Clin North Am 21 2007 711 743 ix (Pubitemid 47362606)
14. CK Cassel, EB Larson, and DE Meier Geriatric Medicine: An Evidence-Based Approach 4th ed 2003 Springer New York, NY 869 882
15. RA Norman Geriatric dermatology Dermatol Ther 16 2003 260 268 (Pubitemid 37288684)
16. JA O'Donnell, and MT Hofman Skin and soft tissues. Management of four common infections in the nursing home patient Geriatrics 56 2001 33 38 41
17. GS Ashcroft, MA Horan, and MW Ferguson The effects of ageing on cutaneous wound healing in mammals J Anat 187 1995 1 26
18. HB Fung, JY Chang, and S Kuczynski A practical guide to the treatment of complicated skin and soft tissue infections Drugs 63 2003 1459 1480 (Pubitemid 36871772)
19. CW Dieffenbach, and EC Tramont Innate (general or nonspecific) host defense mechanisms GL Mandell, JE Bennett, R Dolin, Mandell, Douglas, and Bennett's: Principles and Practice of Infectious Diseases 6th ed. 2005 Elsevier/Churchill Livingstone Philadelphia, Pa 39 40
20. KP High, SF Bradley, and S Gravenstein Clinical practice guideline for the evaluation of fever and infection in older adult residents of long-term care facilities: 2008 Update by the Infectious Diseases Society of America Clin Infect Dis 48 2009 149 171
21. LE Nicolle, LJ Strausbaugh, and RA Garibaldi Infections and antibiotic resistance in nursing homes Clin Microbiol Rev 9 1996 1 17 (Pubitemid 26035535)
22. P Rousseau Immobility in the aged Arch Fam Med 2 1993 166 177 discussion 178
23. R Chernoff Protein and older adults J Am Coll Nutr 23 Suppl 6 2004 627S 630S (Pubitemid 40096752)
24. TR Fritsche, HR Sader, and RN Jones Potency and spectrum of garenoxacin tested against an international collection of skin and soft tissue infection pathogens: Report from the SENTRY Antimicrobial Surveillance Program (19992004) Diagn Microbiol Infect Dis 58 2007 19 26 (Pubitemid 46694276)
25. GJ Moet, RN Jones, and DJ Biedenbach Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: Report from the SENTRY Antimicrobial Surveillance Program (1998- 2004) Diagn Microbiol Infect Dis 57 2007 7 13 (Pubitemid 44908825)
26. MS Dryden Skin and soft tissue infection: Microbiology and epidemiology Int J Antimicrob Agents 34 Suppl 1 2009 S2 S7
27. MP Stevens, and MB Edmond The rising tide: Skin and soft tissue infections due to community-associated methicillin-resistant Staphylococcus aureus South Med J 102 2009 121 122
28. GJ Moran, RN Amii, FM Abrahamian, and DA Talan Methicillin-resistant Staphylococcus aureus in communityacquired skin infections Emerg Infect Dis 11 2005 928 930 (Pubitemid 40720855)
29. GJ Moran, A Krishnadasan, and RJ Gorwitz EMERGEncy ID Net Study Group S Methicillin-resistant aureus infections among patients in the emergency department N Engl J Med 355 2006 666 674
30. E Klein, DL Smith, and R Laxminarayan Communityassociated methicillin-resistant Staphylococcus aureus in outpatients, United States, 19992006 Emerg Infect Dis 15 2009 1925 1930
31. SK Fridkin, JC Hagerman, and M Morrison Methicillin-resistant Staphylococcus aureus disease in three communities [published correction appears in N Engl J Med. 2005; 352:2362] N Engl J Med 352 2005 1436 1444
32. J Maudsley, SP Stone, and CC Kibbler The community prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in older people living in their own homes: Implications for treatment, screening and surveillance in the UK J Hosp Infect 57 2004 258 262 (Pubitemid 38967337)
33. CS Choi, CS Yin, and AA Bakar Nasal carriage of Staphylococcus aureus among healthy adults J Microbiol Immunol Infect 39 2006 458 464 (Pubitemid 46374211)
34. WJ Munckhof, GR Nimmo, and J Carney Methicillinsusceptible, non-multiresistant methicillin-resistant and multiresistant methicillin- resistant Staphylococcus aureus infections: A clinical, epidemiological and microbiological comparative study Eur J Clin Microbiol Infect Dis 27 2008 355 364
35. C Graber Skin and soft tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus BETA 19 2007 20 26
36. AM Bruce, and JM Spencer Prevalence of community-acquired methicillin-resistant Staphylococcus aureus in a private dermatology office J Drugs Dermatol 7 2008 751 755
37. MF Kluytmans-Vandenbergh, and JA Kluytmans Communityacquired methicillin-resistant Staphylococcus aureus: Current perspectives Clin Microbiol Infect 12 Suppl 1 2006 9 15
38. M Bassetti, E Nicco, and M Mikulska Why is community-associated MRSA spreading across the world and how will it change clinical practice Int J Antimicrob Agents 34 Suppl 1 2009 S15 S19
39. JK Johnson, T Khoie, and S Shurland Skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus USA300 clone Emerg Infect Dis 13 2007 1195 1200 (Pubitemid 47359164)
40. JJ Ruhe, N Smith, RW Bradsher, and A Menon Community-onset methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: Impact of antimicrobial therapy on outcome Clin Infect Dis 44 2007 777 784 (Pubitemid 46365300)
41. JD Szumowski, KM Wener, and HS Gold Methicillin-resistant Staphylococcus aureus colonization, behavioral risk factors, and skin and soft-tissue infection at an ambulatory clinic serving a large population of HIV-infected men who have sex with men Clin Infect Dis 49 2009 118 121
42. L Shastry, J Rahimian, and S Lascher Community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections in men who have sex with men in New York City Arch Intern Med 167 2007 854 857 (Pubitemid 46658347)
43. KK Byrd, RC Holman, and MG Bruce Methicillin-resistant Staphylococcus aureus-associated hospitalizations among the American Indian and Alaska native population Clin Infect Dis 49 2009 1009 1015
44. HC Baggett, TW Hennessy, and R Leman An outbreak of community-onset methicillin-resistant Staphylococcus aureus skin infections in southwestern Alaska Infect Control Hosp Epidemiol 24 2003 397 402 (Pubitemid 36818506)
45. F Coronado, JA Nicholas, and BJ Wallace Community-associated methicillin-resistant Staphylococcus aureus skin infections in a religious community Epidemiol Infect 135 2007 492 501 (Pubitemid 46443435)
46. P Tattevin, BA Diep, M Jula, and F Perdreau-Remington Methicillin-resistant Staphylococcus aureus USA300 clone in long-term care facility Emerg Infect Dis 15 2009 953 955
47. P Sendi, L Johansson, and A Norrby-Teglund Invasive group B Streptococcal disease in non-pregnant adults: A review with emphasis on skin and soft-tissue infection Infection 36 2008 100 111
48. MS Edwards, and CJ Baker Group B streptococcal infections in elderly adults Clin Infect Dis 41 2005 839 847 (Pubitemid 41266752)
49. P Bernard, C Bedane, and M Mounier Streptococcal cause of erysipelas and cellulitis in adults: A microbiologic study using a direct immunofluorescence technique Arch Dermatol 125 1989 779 782 (Pubitemid 19161120)
50. IA Critchley, DF Sahm, and C Thornsberry Antimicrobial susceptibilities of Streptococcus pyogenes isolated from respiratory and skin and soft tissue infections: United States LIBRA surveillance data from 1999 Diagn Microbiol Infect Dis 42 2002 129 135 (Pubitemid 34164671)
51. TH Skoff, MM Farley, and S Petit Increasing burden of invasive Group B streptococcal disease in nonpregnant adults, 1990-2007 Clin Infect Dis 49 2009 85 92
52. DL Stevens, AL Bisno, and HF Chambers Practice guidelines for the diagnosis and management of skin and soft-tissue infections Clin Infect Dis 41 2005 1373 1406 [published corrections appear in Clin Infect Dis. 2006;42:1219 and Clin Infect Dis. 2005;41:1830] (Pubitemid 41581713)
53. DN Gilbert, RC Moellering, and GM Eliopoulos The Sanford Guide to Antimicrobial Therapy 39th ed. 2009 Antimicrobial Therapy Inc perryville, Va
54. LM Napolitano Severe soft tissue infections Infect Dis Clin North Am 23 2009 571 591
55. JD Urschel Necrotizing soft tissue infections Postgrad Med J 75 1999 645 649 (Pubitemid 29495595)
56. YS Wang, CH Wong, and YK Tay Staging of necrotizing fasciitis based on the evolving cutaneous features Int J Dermatol 46 2007 1036 1041
57. JD Cunningham, L Silver, and D Rudikoff Necrotizing fasciitis: A plea for early diagnosis and treatment Mt Sinai J Med 68 2001 253 261 (Pubitemid 32717821)
58. JR Zahar, J Goveia, P Lesprit, and C Brun-Buisson Severe soft tissue infections of the extremities in patients admitted to an intensive care unit Clin Microbiol Infect 11 2005 79 82 (Pubitemid 40227830)
59. R Montoya Chinchilla, E Izquierdo Morejon, and B Nicolae Pietricic Fournier's gangrene. Descriptive analysis of 20 cases and literature review [in Spanish] Actas Urol Esp 33 2009 873 880
60. WM Ghnnam Fournier's gangrene in Mansoura Egypt: A review of 74 cases J Postgrad Med 54 2008 106 109
61. SE Efem The features and aetiology of Fournier's gangrene Postgrad Med J 70 1994 568 571 (Pubitemid 24252234)
62. JN Legbo, and BB Shebu Necrotizing fasciitis: A comparative analysis of 56 cases J Natl Med Assoc 97 2005 1692 1697 (Pubitemid 41753116)
63. OL Gunter, OD Guillamondegui, AK May, and JJ Diaz Outcome of necrotizing skin and soft tissue infections Surg Infect (Larchmt) 9 2008 443 450
64. TL Lamagni, S Neal, and C Keshishian Predictors of death after severe Streptococcus pyogenes infection Emerg Infect Dis 15 2009 1304 1307
65. JI Merlino, and MA Malangoni Complicated skin and softtissue infections: Diagnostic approach and empiric treatment options Cleve Clin J Med 74 Suppl 4 2007 S21 S28
66. MP Sachdeva, and KJ Tomecki Cellulitis and Erysipelas D Schlossberg, Clinical Infectious Disease 2008 Cambridge University Press Cambridge, Mass; New York, NY 151 156
67. ME Falagas, DK Matthaiou, and KZ Vardakas Fluoroquinolones vs beta-lactams for empirical treatment of immunocompetent patients with skin and soft tissue infections: A meta-analysis of randomized controlled trials Mayo Clin Proc 81 2006 1553 1566 (Pubitemid 44871899)
68. MJ Kuehnert, HA Hill, and BA Kupronis Methicillinresistant- Staphylococcus aureus hospitalizations, United States Emerg Infect Dis 11 2005 868 872 (Pubitemid 40720847)
69. RM Klevens, MA Morrison, J Nadle Active Bacterial Core surveillance (ABCs) MRSA Investigators Invasive methicillin-resistant Staphylococcus aureus infections in the United States JAMA 298 2007 1763 1771 [published correction appears in Emerg Infect Dis. 2006;12:1472]. (Pubitemid 47598444)
70. J Weigelt, K Itani, D Stevens Linezolid CSSTI Study Group Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections Antimicrob Agents Chemother 49 2005 2260 2266 (Pubitemid 40734452)
71. RL Nichols, DR Graham, SL Barriere Synercid Skin and Skin Structure Infection Group Treatment of hospitalized patients with complicated grampositive skin and skin structure infections: Two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycin J Antimicrob Chemother 44 1999 263 273 [published correction appears in J Antimicrob Chemother. 1999;44:585] (Pubitemid 29389290)
72. ME Stryjewski, DR Graham, SE Wilson Assessment of Telavancin in Complicated Skin and Skin- Structure Infections Study Telavancin versus vancomycin for the treatment of complicated skin and skin structure infections caused by gram-positive organisms Clin Infect Dis 46 2008 1683 1693 (Pubitemid 351706765)
73. RD Arbeit, D Maki, FP Tally Daptomycin 98-01 and 99-01 Investigators The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections Clin Infect Dis 38 2004 1673 1681 (Pubitemid 38781657)
74. J Breedt, J Teras, J Gardovskis Tigecycline 305 cSSSI Study Group Safety and efficacy of tigecycline in treatment of skin and skin structure infections: Results of a double-blind phase 3 comparison study with vancomycin-aztreonam Antimicrob Agents Chemother 49 2005 4658 4666 (Pubitemid 41552597)
75. I Florescu, M Beuran, R Dimov 307 Study Group Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: A Phase 3, multicentre, double-blind, randomized study J Antimicrob Chemother 62 Suppl 1 2008 i17 i28
76. A Kumar, DL Murray, and CB Hanna Comparative study of cephalexin hydrochloride and cephalexin monohydrate in the treatment of skin and soft tissue infections Antimicrob Agents Chemother 32 1988 882 885
77. A Lassus Comparative studies of azithromycin in skin and soft-tissue infections and sexually transmitted infections by Neisseria and Chlamydia species J Antimicrob Chemother 25 Suppl A 1990 115 121 (Pubitemid 20043957)
78. RD Powers Soft tissue infections in the emergency department: The case for the use of 'simple' antibiotics South Med J 84 1991 1313 1315
79. DL Stevens, F Pien, and M Drehobl Comparison of oral cefpodoxime proxetil and cefaclor in the treatment of skin and soft tissue infections Diagn Microbiol Infect Dis 16 1993 123 129 (Pubitemid 23090033)
80. H Tassler Comparative efficacy and safety of oral fleroxacin and amoxicillin/clavulanate potassium in skin and soft tissue infections Am J Med 94 Suppl 3A 1993 159S 165S (Pubitemid 23089448)
81. MM Wasilewski, MG Wilson, GD Sides, and JL Stotka Comparative efficacy of 5 days of dirithromycin and 7 days of erythromycin in skin and soft tissue infections J Antimicrob Chemother 46 2000 255 262 (Pubitemid 30639295)
82. GA Tarshis, BM Miskin, and TM Jones Once-daily oral gatifloxacin versus oral levofloxacin in the treatment of uncomplicated skin and soft tissue infections: Doubleblind, multicenter, randomized study Antimicrob Agents Chemother 45 2001 2358 2362 (Pubitemid 32664479)
83. AD Bucko, BJ Hunt, SL Kidd, and R Hom Randomized, double-blind, multicenter comparison of oral cefditoren 200 or 400 mg BID with either cefuroxime 250 mg BID or cefadroxil 500 mg BID for the treatment of uncomplicated skin and skin-structure infections Clin Ther 24 2002 1134 1147 (Pubitemid 34833235)
84. RW Geckler, RH Eng, and TC Fabian A multicenter comparative study of cefotetan once daily and cefoxitin thrice daily for the treatment of infections of the skin and superficial soft tissue Am J Surg 155 Suppl 5A 1988 91 95
85. LA Mandell, MG Bergeron, and AR Ronald Once-daily therapy with ceftriaxone compared with daily multipledose therapy with cefotaxime for serious bacterial infections: A randomized, double-blind study J Infect Dis 160 1989 433 441
86. H Tassler, W Cullmann, and D Elhardt Therapy of soft tissue infections with piperacillin/tazobactam J Antimicrob Chemother 31 Suppl A 1993 105 112 (Pubitemid 23078102)
87. DL Stevens, LG Smith, and JB Bruss Randomized comparison of linezolid (PNU-100766) versus oxacillin-dicloxacillin for treatment of complicated skin and soft tissue infections Antimicrob Agents Chemother 44 2000 3408 3413 (Pubitemid 33009502)
88. DA Talan, PH Summanen, and SM Finegold Ampicillin/sulbactam and cefoxitin in the treatment of cutaneous and other soft-tissue abscesses in patients with or without histories of injection drug abuse Clin Infect Dis 31 2000 464 471 (Pubitemid 32289577)
89. DR Graham, C Lucasti, and O Malafaia Ertapenem once daily versus piperacillin-tazobactam 4 times per day for treatment of complicated skin and skin-structure in fections in adults: Results of a prospective, randomized, double-blind multicenter study Clin Infect Dis 34 2002 1460 1468 (Pubitemid 34553705)
90. EJ Ellis-Grosse, T Babinchak, N Dartois Tigecycline 300 cSSSI Study Group Tigecycline 305 cSSSI Study Group The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: Results of 2 double-blind phase 3 comparison studies with vancomycin-aztreonam Clin Infect Dis 41 Suppl 5 2005 S341 S353
91. TC Fabian, TM File, and JM Embil Meropenem versus imipenem-cilastatin for the treatment of hospitalized patients with complicated skin and skin structure infections: Results of a multicenter, randomized, double-blind comparative study Surg Infect (Larchmt) 6 2005 269 282 (Pubitemid 41645593)
92. ME Stryjewski, WD O'Riordan, WK Lau FAST Investigator Group Telavancin versus standard therapy for treatment of complicated skin and soft-tissue infections due to gram-positive bacteria Clin Infect Dis 40 2005 1601 1607 (Pubitemid 40720810)
93. D Nathwani, M Morgan, RG Masterton British Society for Antimicrobial Chemotherapy Working Party on Community-onset MRSA Infections Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community J Antimicrob Chemother 61 2008 976 994 [published correction appears in J Antimicrob Chemother. 2008;62:216] (Pubitemid 351545546)
94. MJ Cenizal, D Skiest, and S Luber Prospective randomized trial of empiric therapy with trimethoprimsulfamethoxazole or doxycycline for outpatient skin and soft tissue infections in an area of high prevalence of methicillin- resistant Staphylococcus aureus Antimicrob Agents Chemother 51 2007 2628 2630 (Pubitemid 47047353)
95. JJ Ruhe, and A Menon Tetracyclines as an oral treatment option for patients with community onset skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus Antimicrob Agents Chemother 51 2007 3298 3303 (Pubitemid 350067543)
96. PM Rajendran, D Young, and T Maurer Randomized, double-blind, placebo-controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community-acquired methicillin-resistant Staphylococcus aureus infection Antimicrob Agents Chemother 51 2007 4044 4048 (Pubitemid 350057804)
97. RJ Gorwitz, DB Jernigan, JH Powers, JA Jernigan Participants in the CDC-Convened Experts' Meeting on Management of MRSA in the Community Strategies for clinical management of MRSA in the community: Summary of an expert's meeting convened by the Centers for Disease Control and Prevention http://www.cdc.gov/ ncidod/dhqp/pdf/ar/CAMRSA-ExpMtgStrategies.pdf February 26, 2010 Accessed
98. N Markowitz, EL Quinn, and LD Saravolatz Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection Ann Intern Med 117 1992 390 398
99. AE Miller Selective decline in cellular immune response to varicella-zoster in the elderly Neurology 30 1980 582 587 (Pubitemid 10073082)
100. BL Burke, RW Steele, and OW Beard Immune responses to varicella-zoster in the aged Arch Intern Med 142 1982 291 293 (Pubitemid 12180803)
101. RP Insinga, RF Itzler, and JM Pellissier The incidence of herpes zoster in a United States administrative database J Gen Intern Med 20 2005 748 753 (Pubitemid 41141008)
102. JA Zaia Varicella-Zoster Virus D Schlossberg, Clinical Infectious Disease 2008 Cambridge University Press Cambridge, Mass; New York, NY 1311 1318
103. RG Kost, and SE Straus Postherpetic neuralgiapathogenesis, treatment, and prevention N Engl J Med 335 1996 32 42
104. S Helgason, G Petursson, S Gudmundsson, and JA Sigurdsson Prevalence of postherpetic neuralgia after a first episode of herpes zoster: Prospective study with long term follow up BMJ 321 2000 794 796
105. W Opstelten, NPA Zuithoff, and GA van Essen Predicting postherpetic neuralgia in elderly primary care patients with herpes zoster: Prospective prognostic study Pain 132 Suppl 1 2007 S52 S59
106. KR Beutner, DJ Friedman, and C Forszpaniak Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults Antimicrob Agents Chemother 39 1995 1546 1553
107. SK Tyring, KR Beutner, and BA Tucker Antiviral therapy for herpes zoster: Randomized, controlled clinical trial of valacyclovir and famciclovir therapy in immunocompetent patients 50 years and older Arch Fam Med 9 2000 863 869
108. JL Jackson, R Gibbons, G Meyer, and L Inouye The effect of treating herpes zoster with oral acyclovir in preventing postherpetic neuralgia. A meta-analysis Arch Intern Med 157 1997 909 912 (Pubitemid 28337042)
109. S Tyring, RA Barbarash, JE Nahlik Collaborative Famciclovir Herpes Zoster Study Group Famciclovir for the treatment of acute herpes zoster: Effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial Ann Intern Med 123 1995 89 96
110. MJ Wood, R Kay, and RH Dworkin Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: A meta-analysis of placebo-controlled trials Clin Infect Dis 22 1996 341 347 (Pubitemid 26056166)
111. MW McKendrick, JI McGill, and MJ Wood Lack of effect of acyclovir on postherpetic neuralgia BMJ 298 1989 431 (Pubitemid 19056463)
112. EP Acosta, and HH Balfour Jr Acyclovir for treatment of postherpetic neuralgia: Efficacy and pharmacokinetics Antimicrob Agents Chemother 45 2001 2771 2774 (Pubitemid 32906669)
113. RJ Whitley, H Weiss, JW Gnann Jr National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trial Ann Intern Med 125 1996 376 383 (Pubitemid 126449707)
114. MJ Wood, RW Johnson, and MW McKendrick A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster N Engl J Med 330 1994 896 900 (Pubitemid 24094969)
115. WR Lin, HH Lin, and SS Lee Comparative study of the efficacy and safety of valaciclovir versus acyclovir in the treatment of herpes zoster J Microbiol Immunol Infect 34 2001 138 142 (Pubitemid 32641346)
116. Department of Health and Human Services, Centers for Disease Control and Prevention (CDC) National diabetes fact sheet, 2007: General information. http://www.cdc.gov/diabetes/pubs/pdf/ndfs-2007.pdf March 30, 2010 Accessed
117. AG Mainous III, R Baker, and RJ Koopman Impact of the population at risk of diabetes on projections of diabetes burden in the United States: An epidemic on the way Diabetologia 50 2007 934 940 (Pubitemid 46559242)
118. M Delamaire, D Maugendre, and M Moreno Impaired leucocyte functions in diabetic patients Diabet Med 14 1997 29 34 (Pubitemid 27019919)
119. Centers for Disease Control and Prevention (CDC) Diabetes data & trends: Diabetes complications for lower extremity ulcer/inflammation/infection http://www.cdc.gov/diabetes/statistics/hosplea/diabetes-complications/ fig3-ulcer.htm February 26, 2010 Accessed
120. HR Unalp, E Kamer, and H Derici Fournier's gangrene: Evaluation of 68 patients and analysis of prognostic variables J Postgrad Med 54 2008 102 105 (Pubitemid 351724192)
121. YM Liu, CY Chi, and MW Ho Microbiology and factors affecting mortality in necrotizing fasciitis J Microbiol Immunol Infect 38 2005 430 435
122. BA Lipsky, K Itani, C Norden Linezolid Diabetic Foot Infections Study Group Treating foot infections in diabetic patients: A randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillinclavulanate Clin Infect Dis 38 2004 17 24 (Pubitemid 38045868)
123. BA Lipsky, DG Armstrong, and DM Citron Ertapenem versus piperacillin/tazobactam for diabetic foot infections (SIDESTEP): Prospective, randomized, controlled, double-blinded, multicentre trial Lancet 366 2005 1695 1703 (Pubitemid 41587448)
124. PG Clay, MR Graham, and CC Lindsey Clinical efficacy, tolerability, and cost savings associated with the use of open-label metronidazole plus ceftriaxone once daily compared with ticarcillin/clavulanate every 6 hours as empiric treatment for diabetic lower-extremity infections in older males Am J Geriatr Pharmacother 2 2004 181 189 (Pubitemid 39618443)
125. JM Embil, NE Soto, and DA Melnick A post hoc subgroup analysis of meropenem versus imipenem/cilastatin in a multicenter, double-blind, randomized study of complicated skin and skin-structure infections in patients with diabetes mellitus Clin Ther 28 2006 1164 1174 (Pubitemid 44374752)
126. BA Lipsky, PD Baker, GC Landon, and R Fernau Antibiotic therapy for diabetic foot infections: Comparison of two parenteral-to-oral regimens Clin Infect Dis 24 1997 643 648 (Pubitemid 27143558)
127. BA Lipsky, and U Stoutenburgh Daptomycin for treating infected diabetic foot ulcers: Evidence from a randomized, controlled trial comparing daptomycin with vancomycin or semi-synthetic penicillins for complicated skin and skin-structure infections J Antimicrob Chemother 55 2005 240 245 (Pubitemid 40331152)
128. BA Lipsky, P Giordano, S Choudhri, and J Song Treating diabetic foot infections with sequential intravenous to oral moxifloxacin compared with piperacillin-tazobactam/amoxicillin-clavulanate J Antimicrob Chemother 60 2007 370 376 (Pubitemid 47243888)
129. BA Lipsky, AR Berendt, HG Deery Infectious Diseases Society of America Diagnosis and treatment of diabetic foot infections Clin Infect Dis 39 2004 885 910 (Pubitemid 39328144)
130. RM Allman, PS Goode, and MM Patrick Pressure ulcer risk factors among hospitalized patients with activity limitation JAMA 273 1995 865 870
131. JC Barbenel, MM Jordan, SM Nicol, and MO Clark Incidence of pressure-sores in the Greater Glasgow Health Board Area Lancet 10 1977 548 550 (Pubitemid 8186314)
132. DM Smith Pressure ulcers in the nursing home Ann Intern Med 123 1995 433 442
133. SE Dowd, Y Sun, and PR Secor Survey of bacterial diversity in chronic wounds using pyrosequencing, DGGE, and full ribosome shotgun sequencing BMC Microbiol 8 2008 43
134. BC Cannon, and JP Cannon Management of pressure ulcers Am J Health Syst Pharm 61 2004 1895 1905
135. CS Bryan, CE Dew, and KL Reynolds Bacteremia associated with decubitus ulcers Arch Intern Med 143 1983 2093 2095 (Pubitemid 14225178)
136. JE Galpin, AW Chow, AS Bayer, and LB Guze Sepsis associated with decubitus ulcers Am J Med 61 1976 346 350
137. Bergstrom N, Bennett MA, Carlson CE, et al. Treatment of pressure ulcers. Clinical practice guideline, No. 15. Rockville, Md: US Department of Health and Human Services. Public Health Service, Agency for Health Care Policy and Research. AHCPR Publication No. 95-0652; December 1994.
138. T Wild, S Stremitzer, and A Budzanowski Definition of efficiency in vacuum therapya randomized controlled trial comparing with V.A.C. Therapy Int Wound J 5 2008 641 647
139. J Heukelbach, and H Feldmeier Scabies Lancet 367 2006 1767 1774 (Pubitemid 43767044)
140. G Johnston, and M Sladden Scabies: Diagnosis and treatment BMJ 331 2005 619 622 (Pubitemid 41360778)
141. V Usha, and TV Gopalakrishnan Nair A comparative study of oral ivermectin and topical permethrin cream in the treatment of scabies J Am Acad Dermatol 42 2000 236 240 (Pubitemid 30469620)
142. F Alberici, L Pagani, G Ratti, and P Viale Ivermectin alone or in combination with benzyl benzoate in the treatment of human immunodeficiency virus-associated scabies Br J Dermatol 142 2000 969 972 (Pubitemid 30304610)
143. EN Chouela, AM Abeldao, and G Pellerano Equivalent therapeutic efficacy and safety of ivermectin and lindane in the treatment of human scabies Arch Dermatol 135 1999 651 655 (Pubitemid 29277831)
144. TL Meinking, D Taplin, and JL Hermida The treatment of scabies with ivermectin N Engl J Med 333 1995 26 30
145. K Kawakami, JI Kadota, and K Iida Reduced immune function and malnutrition in the elderly Tohoku J Exp Med 187 1999 157 171
146. RK Chandra Effect of vitamin and trace-element supplementation on immune responses and infection in elderly subjects Lancet 340 1992 1124 1127
147. MN Oxman, MJ Levin, GR Johnson Shingles Prevention Study Group A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults N Engl J Med 352 2005 2271 2284
148. SC Sutradhar, WW Wang, and K Schlienger Comparison of the levels of immunogenicity and safety of Zostavax in adults 50 to 59 years old and in adults 60 years or older Clin Vaccine Immunol 16 2009 646 652
149. Centers for Disease Control and Prevention Prevention of Herpes Zoster MMWR Early Release 57 2008 1 40
150. M McCollum, SV Sorensen, and LZ Liu A comparison of costs and hospital length of stay associated with intravenous/oral linezolid or intravenous vancomycin treatment of complicated skin and soft-tissue infections caused by suspected or confirmed methicillin-resistant Staphylococcus aureus in elderly US patients Clin Ther 29 2007 469 477 (Pubitemid 46907284)
151. US Census Bureau International database. Table 094: Midyear population, by age and sex Issued January 13, 2000. http://www.census.gov/population/www/ projections/natdet-D1A.html February 26, 2010 Accessed